4554 — Fuji Pharma Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual income statement for Fuji Pharma Co, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	33,793	33,990	35,426	40,889	46,138
Cost of Revenue
Gross Profit	14,872	14,751	14,559	16,515	17,844
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	30,723	30,675	31,937	36,787	40,914
Operating Profit	3,070	3,315	3,489	4,102	5,224
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,918	3,371	3,723	4,399	8,276
Provision for Income Taxes
Net Income After Taxes	2,086	2,433	2,697	3,436	6,148
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,086	2,433	2,697	3,436	6,148
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,085	2,432	2,696	3,435	6,146
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	77.5	102	131	147	226
Dividends per Share